Abstract:The development of the nigrostriatal dopaminergic (DA) pathway in the brain involves many transcriptional and chemotactic molecules, and a deficiency of these molecules can cause nigrostriatal tract defects. However, the role of the end product, dopamine, in nigrostriatal pathway development has not been described. In the present study, we analyzed a mouse model of congenital dopamine and serotonin deficiency, namely, the aromatic l-amino acid decarboxylase (AADC) deficiency (DdcKI) mouse model. We found via tyrosine hydroxylase (TH) immunofluorescence staining that the number of DA fibers in the stratum of 14-day-old DdcKI mice decreased. In TH-stained cleared whole brains of DdcKI mice, the numbers of DA neurons in the substantia nigra (SN) and the number of DA nerve bundles leaving the SN were both normal. However, we found that the nigrostriatal bundles in DdcKI mice were dispersed, taking aberrant routes to the striatum and spreading over a wide area. The total volume occupied by the nigrostriatal tract was increased, and the fraction of TH staining in the tract was decreased in DdcKI mice. Single-nucleus RNA sequencing analysis for mice 0, 7, and 14 days of age, revealed delayed axonogenesis and synapse formation in the striatum of DdcKI mice. The CellChat program inferred less cell-cell communication between striatal D1/D2 neurons but increased cell-cell communication involving neural precursors in DdcKI mice. Therefore, a congenital deficiency in dopamine affects nigrostriatal axon extension and striatal innervation. These nigrostriatal tract defects may limit the treatment efficacy for patients with TH or AADC deficiency.

Research Progress of Dopa Decarboxylase and Its Correlation with Neurological Diseases

Structure-Based Specific Detection And Inhibition Of Monoamine Oxidases And Their Applications In Central Nervous System Diseases

A Study for Therapeutic Treatment Against Parkinson’s Disease Via Chou’s 5-Steps Rule

Progress in Research on the Effects of Dopamine and Its Receptor on the Central Nervous System

Dopa decarboxylase: a model gene-enzyme system for studying development, behavior, and systematics

Crystal Structure and Substrate Specificity of Drosophila 3,4-Dihydroxyphenylalanine Decarboxylase.

The neurodevelopmental role of dopaminergic signaling in neurological disorders

Behavior of fluorinated analogs of l-(3,4-dihydroxyphenyl)alanine and l-threo-(3,4-dihydroxyphenyl)serine as substrates for Dopa decarboxylase

Progresses on study of epigenetics in neurodegenerative disorders

Novel inhibitors of human DOPA decarboxylase extracted from Euonymus glabra Roxb.

Integrating the Roles of Midbrain Dopamine Circuits in Behavior and Neuropsychiatric Disease

Unraveling the Molecular Determinants of Catalytic Efficiency and Substrate Specificity in L-Amino Acid Decarboxylases

Research progress on the roles of dopamine and dopamine receptors in digestive system diseases

Research progress of dopamine dysregulation syndrome in Parkinson disease

Nigrostriatal tract defects in mice with aromatic l-amino acid decarboxylase deficiency

Dopamine: Functions, Signaling, and Association with Neurological Diseases

Recent Advances Towards the Discovery of Dopamine Receptor Ligands

Source, metabolism and function of dopamine in digestive tract

The DOPA Decarboxylase (DDC) Gene is Associated with Alerting Attention

Impact of dopamine oxidation on dopaminergic neurodegeneration.

Polymorphism of the Dopa-Decarboxylase Gene Modifies the Motor Response to Levodopa in Chinese Patients with Parkinson's Disease